Early Stage of Outbreak | | Investigations | | Outbreak Summary | | Aftermath |
CDC and state health department officials noticed a substantial increase in the reported incidence of isolates of Salmonella serotype Tennessee in November 2006.
PulseNet officials noted a substantial increase in the number of isolates of the outbreak strain of Salmonella serotype Tennessee.
The initial investigation showed that cases were not clustered geographically.
From November - December 2006, state and local officials from OutbreakNet conducted patient interviews.
A multistate case-control study (with 65 patients and 124 controls in order to identify the food item associated with illness) was conducted from February 5-13, 2007.
In this study,
On February 13, 2007, epidemiologic data implicating Peter Pan brands of peanut butter as the potential source of the outbreak were provided to FDA officials.
As of February 14, 2007
FDA issued a health alert to consumers indicating that they should not eat Peter Pan or Great Value peanut butter with a product code beginning with 2111.
|
![]() |
Two closely related DNA fingerprints of S Tennessee were associated with the outbreak according to the CDC. DNA patterns were identified through PulseNet, a national network of public health laboratories. S enterica typically causes fever and nonbloody diarrhea that resolves in a week.
Of 120 patients for whom clinical information was available, 31 (26%) were hospitalized.
In addition, up to two new cases were being reported nationwide each day in January, the CDC said.
A CDC alert sent to public health workers said illness onset dates was known for 140 patients and range from Aug 1, 2006 to Jan 21.
The FDA notified its counterpart agencies in Canada and Mexico, the World Health Organizations' INFOSAN Food Safety reporting program and the food safety authority at the European Commission of the outbreak
Both of the products (Peter Pan or Great Value peanut butter with a product code beginning with 2111 ) were manufactured in a single facility in Georgia operated by ConAgra Foods. The FDA sent a team of microbiologists and experienced field investigators to begin its inspection of ConAgra’s manufacturing plant in Georgia. The inspection will include collecting environmental, raw ingredient and product samples, and reviewing manufacturing and quality assurance records.
The plant ceased production and recalled both products on February 14, 2007 based on the findings of the case-control study. Nearly a year after Salmonella started sprouting up around the country, ConAgra issued a recall of Peter Pan and Great Value brand peanut butter.
New case reports decreased substantially after the product recall began.
As of April 6, 2007,
Two closely related DNA fingerprints of S Tennessee were associated with the outbreak according to the CDC. DNA patterns were identified through PulseNet, a national network of public health laboratories. S enterica typically causes fever and nonbloody diarrhea that resolves in a week.
FDA isolated Salmonella Tennessee from 13 unopened jars of Peter Pan and Great Value peanut butter with production dates ranging from August 2006 to January 2007 and from two plant environmental samples.
The outbreak strain of Salmonella Tennessee subsequently was isolated from 21 opened and unopened peanut butter jars with production dates ranging from July 2006 to December 2006. These jars were collected from patients in 13 states (Arkansas, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Minnesota, New York, Oklahoma, Pennsylvania, South Carolina, and Tennessee). Two of the PFGE strains were isolated from these peanut butter samples.
As of March 7, 2007, 425 persons infected with the outbreak strain of Salmonella Tennessee had been reported to CDC from 44 states.
As of April 2007, Washington Post published documents proving that the FDA and ConAgra were aware of contamination problems at the Sylvester, Georgia plant, where the peanut butter was made, as far back as 2004. FDA took few corrective measures, assuming that ConAgra would address the situation itself.
As of May 22, 2007, total of 628 persons infected with an outbreak strain of Salmonella serotype Tennessee had been reported from 47 states since August 1, 2006.
Late June 2007, the CDC reported that 628 people in 47 states were confirmed to have contracted Salmonella from the peanut butter.
Criticism:
Critics assert that under-funding and a lack of trained inspectors at the FDA have left the nation’s food supply in a dangerous condition
A 2006 congressional fact sheet published by Henry Waxman (D-Calif) said:
Peter Pan Back:
ConAgra plans to reintroduce Peter Pan in July or August this year
The company says it will contract with another factory to make the peanut butter until renovations are completed at the Sylvester plant. These renovations are meant to eliminate the moisture problems that ConAgra says contributed to the Salmonella poisoning.
ConAgra is planning a marketing extravaganza that it hopes will cause this year’s Salmonella disaster to fade from its customers’ memories.
Lawsuits:
In July 2007, Krystina Burgh’s parents, who have mounting medical bills, filed suit in Indiana against ConAgra, alleging that the company’s negligence is to blame for her illness. The family says it also hopes the lawsuit will highlight the FDA’s inability to regulate the food industry.
Timothy Harper, a resident of Nashville, Tennessee, is also suing Con-Agra. He claims that he had to be hospitalized with Salmonella poisoning after eating the same brand of the peanut butter. He has accused ConAgra foods of negligence, and has charged that the company with violating the Tennessee Products Liability Act.
Investigations
Surveillance